Fetomaternal cell trafficking and the stem cell debate: Gender matters

JAMA

Volumn 297, Issue 13, 2007, Pages 1489-1491

  Bianchi, Diana W ^a,c   Fisk, Nicholas M ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DIFFERENTIATION; CELL MIGRATION; CELL POPULATION; CLINICAL TRIAL; EMBRYONIC STEM CELL; FETUS CELL; HUMAN; MEDICAL INFORMATION; META ANALYSIS; MICROCHIMERISM; NONHUMAN; NOTE; PREGNANCY; PREGNANCY TERMINATION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SYSTEMATIC REVIEW; Y CHROMOSOME; ADULT; ARTICLE; BLOOD; CHIMERA; CYTOLOGY; FEMALE; FETAL STEM CELL; FETOMATERNAL TRANSFUSION; MALE;

ADULT; CHIMERA; FEMALE; FETAL STEM CELLS; HUMANS; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY;

EID: 34047223048     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.297.13.1489     Document Type: Note

References (25)

1. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41-49.
2. Liégeois A, Escourrou J, Ouvré E, Charreire J. Microchimerism: a stable state of low-ratio proliferation of allogeneic bone marrow. Transplant Proc. 1977;9:273-276.
3. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A. 1996;93:705-708.
4. Evans PC, Lambert N, Maloney S, Furst DE, Moore JM, Nelson JL. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood. 1999;93:2033-2037.
5. Guetta E, Gordon D, Simchen MJ, Goldman B, Barkai G. Hematopoietic progenitor cells as targets for non-invasive prenatal diagnosis: detection of fetal CD34+ cells and assessment of post-delivery persistence in the maternal circulation. Blood Cells Mol Dis. 2003;30:13-21.
6. Adams KM, Lambert NC, Heimfeld S, et al. Male DNA in female donor apheresis and CD34 enriched products. Blood. 2003;102:3845-3847.
7. Ohtsuka T, Miyamoto Y, Yamakage A, Yamazaki S. Quantitative analysis of microchimerism in systemic sclerosis skin tissue. Arch Dermatol Res. 2001;293:387-391.
8. Srivatsa B, Srivatsa S, Johnson KL, Samura O, Lee SL, Bianchi DW. Microchimerism of presumed fetal origin in thyroid specimens from women: a casecontrol study. Lancet. 2001;358:2034-2038.
9. Klintschar M, Immel UD, Kehlen A, et al. Fetal microchimerism in Hashimoto's thyroiditis: a quantitative approach. Eur J Endocrinol. 2006;154:237-241.
10. Johnson KL, McAlindon TE, Mulcahy E, Bianchi DW. Microchimerism in a female patient with systemic lupus erythematosus. Arthritis Rheum. 2001;44:2107-2111.
11. Stevens AM, McDonnell WM, Mullarkey ME, Pang JM, Leisenring W, Nelson JL. Liver biopsies from human females contain male hepatocytes in the absence of transplantation. Lab Invest. 2004;84:1603-1609.
12. Bianchi DW, Farina A, Weber W, et al. Significant fetal-maternal hemorrhage after termination of pregnancy: implications for the development of fetal cell microchimerism. Am J Obstet Gynecol. 2001;184:703-706.
13. Khosrotehrani K, Johnson KL, Lau J, Dupuy A, Cha DH, Bianchi DW. The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review. Arthritis Rheum. 2003;48:3237-3241.
14. Yan Z, Lambert NC, Guthrie KA, et al. Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history. Am J Med. 2005;118:899-906.
15. Johnson KL, Samura O, Nelson JL, McDonnell M, Bianchi DW. Significant fetal cell micro-chimerism in a non-transfused woman with hepatitis C: evidence of long-term survival and expansion. Hepatology. 2002;36:1295-1297.
16. Nelson JL. Viewpoint maternal-fetal immunology and autoimmune disease: some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis Rheum. 1996;39:191-194.
17. Koopmans M, Kremer Hovinga IC, Baelde HJ, et al. Chimerism in kidneys, livers, and hearts of normal women: implications for transplantation studies. Am J Transplant. 2005;5:1495-1502.
18. Khosrotehrani K, Johnson KL, Cha DH, Salomon RN, Bianchi DW. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA. 2004;292:75-80.
19. Christner PJ, Artlett CM, Conway RF, Jimenez SA. Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride. Arthritis Rheum. 2000;43:2598-2605.
20. Imaizumi M, Pritsker A, Unger P, Davies TF. Intrathyroidal fetal microchimerism in pregnancy and postpartum. Endocrinology. 2002;143:247-253.
21. Tan XW, Liao H, Sun L, Okabe M, Xiao ZC, Dawe GS. Fetal microchimerism in the maternal mouse brain: a novel population of fetal progenitor or stem cells able to cross the blood-brain barrier? Stem Cells. 2005;23:1443-1452.
22. Wang Y, Iwatani H, Ito T, et al. Fetal cells in mother rats contribute to the remodeling of liver and kidney after injury. Biochem Biophys Res Commun. 2004; 325:961-967.
23. O'Donoghue K, Choolani N, Chan J, et al. Identification of fetal mesenchymal stem cells in maternal blood: implications for non-invasive prenatal diagnosis. Mol Hum Reprod. 2003;9:497-502.
24. O'Donoghue K, Chan J, de la Fuente J, et al. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet. 2004;364:179-182.
25. Tokita K, Terasaki P, Maruya E, Saji H. Tumour regression following stem cell infusion from daughter to microchimeric mother. Lancet. 2001;358:2047-2048.